StockData
Dare Bioscience, Inc. logo

Dare Bioscience, Inc. (DARE) stock

DARENasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 5/30
$0.43−0.16 (-26.57%)

Close on Nov 17, 2026Market cap $6.56MP/E –Yield –

Dare Bioscience total debt

Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.

Dare Bioscience's total debt was $10.54K at Sep 30, 2025. For fiscal 2024 it was $4.05K.

Annual total debt

PeriodPeriod endValueChange
FY2024Dec 31, 2024$4.05K–

Quarterly total debt

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2025Sep 30, 2025$10.54K–
Q2 FY2025Jun 30, 2025$187.97K–
Q1 FY2025Mar 31, 2025$91.91K–
Q4 FY2024Dec 31, 2024$4.05K–

More Dare Bioscience figures

See a number that looks wrong?